Oxidation of DJ-1 in blood and brain of Parkinsons disease patients- usability as an early diagnosis marker
Treating cells with L-buthionine sulfoximine (BSO), an inhibitor that blocks the synthesis of GSH, renders neuronal SH-SY5Y cells expressing mutant valosin-containing protein (VCP) R487H more susceptible to oxidative stress (Hirano et al., 2015) and increases mutant SOD1 toxicity (Alvarez-Zaldiernas et al., 2016
My surgery was a HUGE success
Over time, youll build a personal shortlist that turns the lobby into a set of reliable checkpoints rather than a maze
Neurotoxicology 29:190201 Muratore CR, Hodgson NW, Trivedi MS, Abdolmaleky HM, Persico AM, Lintas C, De La Monte S, Deth RC (2013)
When OXM was administered over a 4 day period to human subjects there was an observed 10% increase in total energy expenditure